Cytokinetics (CYTK) Net Preferred Shares Issued and Repurchased (2012)
Cytokinetics' Net Preferred Shares Issued and Repurchased came in at $12.32 million for FY2012, up 32.0% from $9.33 million in FY2011.
Powered by 
Analysis
Cytokinetics (CYTK) Net Preferred Shares Issued and Repurchased (2012) Analysis & Trends
- Per Business Quant, earlier years put Net Preferred Shares Issued and Repurchased at $9.33 million in FY2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Pref. Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Cytokinetics | 9.12 Bn | 5.29 Bn | 25.89 Mn | - |
API Access
Cytokinetics Net Preferred Shares Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=CYTK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-preferred-shares-issued-and-repurchased", "ticker": "CYTK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=CYTK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();